Listed players
SST2.44▼ -7.58%TIG40.00▲ +3.90%TEAD0.56▲ +3.77%PERI8.50▼ -2.97%TBLA3.23▼ -2.71%INUV0.57▼ -1.74%AV10.06▼ -1.59%GOOGL343.50▲ +1.56%SNAP5.58▼ -1.24%PINS19.26▼ -1.03%MSFT517.53▲ +0.92%PPLI41.28▲ +0.81%IOS32.24▲ +0.44%META728.08▲ +0.30%GDDY97.21▲ +0.24%DV13.49▲ 0.00%MCHX1.29▲ 0.00%
Ticker byClearTrust

Marchex

Seattle firm that bet on type-in domain traffic in 2004, sold the names to GoDaddy in 2015, now does call analytics.

Seattle, Washington, USA · founded 2003 · marchex.com

MCHX NASDAQ

Presented byClearTrust· Clean traffic is good business. Measure yours with the TQI Score™.
$1.29 USD
(—)
Market cap $57.2M
52-week 1.15–2.04
Delayed · 14m ago · nasdaq
$1.23$1.60$1.98Oct 25Jan 26Apr 26Jul 26Oct 26

What Marchex does

Marchex is the best-documented case of a listed company built on direct navigation. In November 2004 it agreed to buy the assets of Name Development, a holder of a very large portfolio of domain names, for about $164 million in cash and stock. The idea was that people type words straight into the address bar, and a page of ads on those names earns money with no marketing cost.

The bet aged badly as browsers and search engines changed how people navigate. In April 2015 Marchex sold more than 200,000 domains to GoDaddy for $28.1 million, a fraction of what it had paid.

Today Marchex sells call-tracking and conversation analytics to businesses and has no role in search feeds. It is still listed on Nasdaq.

How it makes money

Today, software subscriptions for call analytics. Historically, pay-per-click ads on its own domains.

Products

  • Marchex call analytics
  • Domain portfolio (sold 2015)

Quarterly revenue

From SEC XBRL filings · latest quarter -5.6% year on year
$12.6M'24 Q3$11.9M'24 Q4$11.4M'25 Q1$11.7M'25 Q2$11.5M'25 Q3$10.8M'25 Q4$10.6M'26 Q1$11.0M'26 Q2

Quarterly net income

$-831000.00'24 Q3$-1.9M'24 Q4$-2.0M'25 Q1$85000.00'25 Q2$-1.0M'25 Q3$-2.3M'25 Q4$-1.7M'26 Q1$-408000.00'26 Q2
Fiscal year20212022202320242025
Revenue$53.5M$52.2M$49.9M$48.1M$45.4M
Net income$-4.4M$-8.2M$-9.9M$-4.9M$-5.2M
Diluted EPS$-0.10$-0.19$-0.23$-0.11$-0.12

Earnings, explained

Aug 12, 2026 · 8-K item 2.02

Marchex Q2 revenue dips, but profitability improves post-Archenia acquisition

Q2 2026 Revenue $11.0 millionQ2 2025 Revenue $11.7 millionQ2 2026 Net Loss $0.4 million or $(0.01) per diluted shareQ2 2026 Adjusted EBITDA $0.7 million (includes $1.0 million in related costs)Pro Forma Q2 2026 Revenue $15.5 millionQ3 2026 Pro Forma Revenue Outlook $16.0–$16.5 million

Marchex reported Q2 2026 revenue of $11.0 million, down from $11.7 million in Q2 2025. The company posted a net loss of $0.4 million, compared to net income of $0.1 million a year earlier. Adjusted EBITDA improved to $0.7 million, up from $0.6 million, and would have been $1.7 million excluding $1.0 million in reorganization and acquisition costs. Looking ahead, pro forma combined revenue for Q3 2026 is expected to be $16.0–$16.5 million, with adjusted EBITDA of $2.3–$2.5 million.

Despite a slight drop in standalone revenue, Marchex is showing early signs of improved profitability and growth potential following its acquisition of Archenia. The company is betting on new AI-driven products and cross-selling to its top customers to drive future revenue and margin expansion.

Read the press release on SEC.gov

SEC filings

EDGAR
FiledFormWhat it is
2026-08-1310-QQuarterly report
2026-08-128-KResults of operations (earnings) · Financial statements and exhibits
2026-07-018-KMaterial agreement · Acquisition or sale completed · Item 2.03 · Item 3.02 · Shareholder vote · Financial statements and exhibits
2026-06-05DEFM14APROXY STATEMENT
2026-05-1410-QQuarterly report
2026-05-138-KResults of operations (earnings) · Financial statements and exhibits
2026-05-128-KMaterial agreement
2026-05-018-KMaterial agreement · Impairment
2026-04-1710-K/AAnnual report
2026-04-158-KMaterial agreement
2026-03-2610-KAnnual report
2026-03-258-KResults of operations (earnings) · Financial statements and exhibits
2026-02-188-KMaterial agreement · Executive or director change
2026-01-308-KMaterial agreement · Executive or director change
2025-12-178-KMaterial agreement · Executive or director change · Shareholder vote
2025-11-1410-QQuarterly report
2025-11-138-KMaterial agreement · Results of operations (earnings) · Financial statements and exhibits
2025-11-04DEF 14ADEF 14A
2025-10-178-KMaterial agreement · Executive or director change
2025-09-168-KMaterial agreement · Executive or director change · Financial statements and exhibits